Table 2.
CMR parameter
| Parameter | All patients (n = 146) | Patients without endpoint (n = 112) | Patients with endpoint (n = 34) | P-value |
|---|---|---|---|---|
| LVEDV (mL) | 291 ± 102 | 276 ± 88 | 341 ± 127 | 0.05 |
| LVEDV/BSA (mL/m2) | 148 ± 50 | 140 ± 41 | 175 ± 66 | <0.0001 |
| LVESV (mL) | 214 ± 104 | 195 ± 86 | 275 ± 132 | <0.0001 |
| LVESV/BSA (mL/m2) | 108 ± 52 | 98 ± 41 | 143 ± 69 | <0.0001 |
| LVEF (%) | 29.3 ± 11.0 | 31.5 ± 10.1 | 22.0 ± 10.9 | <0.0001 |
| LVGFI (%) | 20.3 ± 8.0 | 22.0 ± 7.5 | 14.8 ± 7.2 | <0.0001 |
| Cardiac output (L/min) | 5.5 ± 1.6 | 5.6 ± 1.6 | 5.1 ± 1.7 | NS |
| Cardiac output index (L/min*m2) | 2.8 ± 0.8 | 2.9 ± 0.7 | 2.6 ± 0.8 | <0.05 |
| LGE present, n (%) | 64 (44) | 44 (39) | 20 (59) | <0.05 |
| LAS (%) | −7.7 ± 3.4 | −8.5 ± 3.2 | −5.1 ± 2.6 | <0.0001 |